Comments on Proposed Criteria for “First Generic” Submissions for Purposes of ANDA Review Prioritization Under GDUFA

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115